Advertisement
Screener

Tribute Pharmaceuticals Canada Inc. Retained Earnings

Tribute Pharmaceuticals Canada Inc. Retained Earnings

Tribute Pharmaceuticals Canada Inc. had Retained Earnings of -CAD 32.33 million as of 2015-09-30, per its 10-Q filed 2015-11-09.

Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent

us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2016-01-29

  • 2015-09-30: Retained Earnings (Accumulated Deficit) -32.33M CAD.
  • 2015-06-30: Retained Earnings (Accumulated Deficit) -33.91M CAD.
  • 2015-03-31: Retained Earnings (Accumulated Deficit) -25.08M CAD.
  • 2014-12-31: Retained Earnings (Accumulated Deficit) -19.90M CAD.

CAD

Period endRetained Earnings (Accumulated Deficit)
2015-09-30-32.33M CAD
10-Q · filed 2015-11-09
2015-06-30-33.91M CAD
10-Q · filed 2016-01-29
2015-03-31-25.08M CAD
10-Q · filed 2016-01-29
2014-12-31-19.90M CAD
10-Q · filed 2016-01-29
2014-09-30-18.94M CAD
10-Q · filed 2015-11-09
2014-06-30-21.98M CAD
10-Q · filed 2016-01-29
2014-03-31-17.58M CAD
10-Q · filed 2016-01-29
2013-12-31-14.30M CAD
10-Q · filed 2016-01-29
2013-09-30-14.01M CAD
10-Q · filed 2014-11-10
2013-06-30-11.43M CAD
10-Q · filed 2014-11-10
2013-03-31-10.44M CAD
10-Q · filed 2014-08-11
2012-12-31-7.72M CAD
10-Q · filed 2014-11-10
2012-09-30-6.45M CAD
10-Q · filed 2013-11-14
2012-06-30-5.73M CAD
10-Q · filed 2013-11-14
2012-03-31-5.00M CAD
10-Q · filed 2013-08-13
2011-12-31-4.37M CAD
10-Q · filed 2013-11-14
2011-09-30-3.99M CAD
10-Q · filed 2012-11-14
2011-06-30-4.10M CAD
10-Q · filed 2012-11-14
2011-03-31-4.16M CAD
10-Q/A · filed 2012-09-13
2010-12-31-3.85M CAD
10-Q · filed 2012-11-14

USD

Period endRetained Earnings (Accumulated Deficit)
2012-03-31-$5.00M
10-Q · filed 2012-05-15
2011-12-31-$4.37M
10-Q · filed 2012-05-15
2011-09-30-$3.99M
10-Q · filed 2011-11-14
2011-06-30-$4.10M
10-Q/A · filed 2011-08-22
2011-03-31-$4.16M
10-Q · filed 2012-05-15
2010-12-31-$3.85M
10-Q · filed 2012-05-15
2010-06-30-$4.27M
10-Q/A · filed 2011-08-22
2010-03-31-$4.63M
10-Q/A · filed 2011-08-22
2009-12-31-$4.38M
10-Q/A · filed 2011-08-22